comparemela.com
Home
Live Updates
Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels in Patients with Phenylketonuria Treated with SYNB1618 : comparemela.com
Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels in Patients with Phenylketonuria Treated with SYNB1618
/PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage company bringing the transformative potential of synthetic biology to medicine, today announced...
Related Keywords
Australia
,
Cambridge
,
Cambridgeshire
,
United Kingdom
,
Sydney
,
New South Wales
,
Aoife Brennan
,
Jerry Vockley
,
International Congress
,
Prnewswire Synlogic Inc
,
Synlogic Inc
,
Nasdaq
,
Inborn Errors
,
Metabolism Meeting
,
Medical Genetics
,
Synthetic Biotic
,
Synlogic President
,
Chief Executive
,
Synthetic Biotics
,
Private Securities Litigation Reform Act
,
Synlogic
,
Nc
,
comparemela.com © 2020. All Rights Reserved.